These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16998554)

  • 1. [Dosaging of proton pumps inhibitors].
    Brørs O
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2397-9. PubMed ID: 16998554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dosaging of proton pumps inhibitors].
    Lundin KE; Kett K
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2985; author reply 2985. PubMed ID: 17117203
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent anaphylaxis linked to pantoprazole.
    Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
    J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacogenomical aspects of gastroesophageal reflux disease].
    Isaev VA
    Vestn Ross Akad Med Nauk; 2005; (6):33-6. PubMed ID: 16022110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
    Park SH
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
    Asano M; Taniwaki H; Tsuji D; Sato Y; Shimizu T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():450-3. PubMed ID: 16416832
    [No Abstract]   [Full Text] [Related]  

  • 7. [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].
    Shirai N; Furuta T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():439-44. PubMed ID: 11979823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Investigation about 3rd line eradication of H. pylori].
    Nakagawa S; Kato M; Shimizu Y; Nakagawa M; Asaka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():466-9. PubMed ID: 16363580
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug interactions. Proton pump inhibitors II].
    Zaigler M
    Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
    [No Abstract]   [Full Text] [Related]  

  • 10. CYP2C19 genotype and the PPIs--focus on rabeprazole.
    Lim PW; Goh KL; Wong BC
    J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
    Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
    Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent topics on important drugs for H. pylori eradication: Rabeprazole].
    Sugimoto M; Furuta T; Nakmura A; Shirai N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():350-3. PubMed ID: 16363558
    [No Abstract]   [Full Text] [Related]  

  • 13. Apparent anaphylaxis associated with pantoprazole.
    Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
    Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
    Meyer UA
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of non-response in Helicobacter pylori eradication trials.
    Klotz U; Treiber G; Schwab M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1471. PubMed ID: 16105147
    [No Abstract]   [Full Text] [Related]  

  • 16. [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
    Shirai N; Furuta T; Sugimoto M; Nakamura A
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():438-41. PubMed ID: 16363575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

  • 18. [When sour does not make merry at all . Fast relief for patients with reflux].
    MMW Fortschr Med; 2003 Apr; 145(15):64. PubMed ID: 15104274
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which proton pump inhibitor should we use?
    Williams CN
    Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.